Patents by Inventor Tomohiro KAGAWA

Tomohiro KAGAWA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HEAT EXCHANGER
    Publication number: 20240110087
    Abstract: A heat exchanger including an aluminum substrate, and a water-repellent coating provided on a surface of the aluminum substrate, wherein the aluminum substrate has an anodized film on the surface, and the water-repellent coating is a film formed of a fluoropolyether group-containing compound.
    Type: Application
    Filed: November 20, 2023
    Publication date: April 4, 2024
    Applicant: DAIKIN INDUSTRIES, LTD.
    Inventors: Michiru KAGAWA, Masamichi Morita, Ryo Inoue, Hiroki Yamaguchi, Tomohiro Nagano, Masatoshi Nose
  • Citric acid derivative
    Patent number: 11001573
    Abstract: Compounds (citric acid derivatives) represented by formulas (1) and (2) below are novel compounds having an inhibitory effect against liver disorder and can be used as liver disorder inhibitors and food additives (wherein R1 represents a C1 to C3 alkyl group optionally having a carboxyl group or a hydroxyl group, and R2 represents a hydrogen atom, or R1 and R2 optionally form a cyclic structure together to represent a C2 to C3 alkylene chain).
    Type: Grant
    Filed: October 15, 2019
    Date of Patent: May 11, 2021
    Assignees: ADABIO CO., LTD., OTSUKA PHARMACEUTICAL FACTORY, INC.
    Inventors: Katsuya Hiraishi, Fumie Jimma, Hiroyuki Soma, Taro Adachi, Masakazu Adachi, Ippei Yamaoka, Tomohiro Kagawa
  • Prophylactic and/or therapeutic agent for NAFLD/NASH
    Patent number: 10610558
    Abstract: The present invention provides a prophylactic and/or therapeutic agent for non-alcoholic fatty liver disease (NAFLD), and particularly non-alcoholic steatohepatitis (NASH) comprising an ume (Japanese apricot) juice concentrate or a processed product thereof. The prophylactic and/or therapeutic agent is obtained by utilizing a component contained in a plant or a processed product thereof, and hence is safe and easily taken. It has been confirmed that when the ume juice concentrate or the processed product thereof is orally administered to a streptozocin (STZ)-induced NAFLD model mouse or an STZ-induced NASH model mouse, liver fibrogenesis can be reduced.
    Type: Grant
    Filed: November 25, 2016
    Date of Patent: April 7, 2020
    Assignees: ADABIO CO., LTD., OTSUKA PHARMACEUTICAL FACTORY, INC.
    Inventors: Katsuya Hiraishi, Fumie Jimma, Hiroyuki Soma, Taro Adachi, Masakazu Adachi, Ippei Yamaoka, Tomohiro Kagawa
  • NOVEL CITRIC ACID DERIVATIVE
    Publication number: 20200039964
    Abstract: Compounds (citric acid derivatives) represented by formulas (1) and (2) below are novel compounds having an inhibitory effect against liver disorder and can be used as liver disorder inhibitors and food additives (wherein R1 represents a C1 to C3 alkyl group optionally having a carboxyl group or a hydroxyl group, and R2 represents a hydrogen atom, or R1 and R2 optionally form a cyclic structure together to represent a C2 to C3 alkylene chain).
    Type: Application
    Filed: October 15, 2019
    Publication date: February 6, 2020
    Applicants: ADABIO CO., LTD., OTSUKA PHARMACEUTICAL FACTORY, INC.
    Inventors: Katsuya HIRAISHI, Fumie JIMMA, Hiroyuki SOMA, Taro ADACHI, Masakazu ADACHI, Ippei YAMAOKA, Tomohiro KAGAWA
  • Citric acid derivative
    Patent number: 10494362
    Abstract: Compounds (citric acid derivatives) represented by formulas (1) and (2) below are novel compounds having an inhibitory effect against liver disorder and can be used as liver disorder inhibitors and food additives (wherein R1 represents a C1 to C3 alkyl group optionally having a carboxyl group or a hydroxyl group, and R2 represents a hydrogen atom, or R1 and R2 optionally form a cyclic structure together to represent a C2 to C3 alkylene chain).
    Type: Grant
    Filed: November 1, 2016
    Date of Patent: December 3, 2019
    Assignees: ADABIO CO., LTD., OTSUKA PHARMACEUTICAL FACTORY, INC.
    Inventors: Katsuya Hiraishi, Fumie Jimma, Hiroyuki Soma, Taro Adachi, Masakazu Adachi, Ippei Yamaoka, Tomohiro Kagawa
  • NOVEL CITRIC ACID DERIVATIVE
    Publication number: 20180334452
    Abstract: Compounds (citric acid derivatives) represented by formulas (1) and (2) below are novel compounds having an inhibitory effect against liver disorder and can be used as liver disorder inhibitors and food additives (wherein R1 represents a C1 to C3 alkyl group optionally having a carboxyl group or a hydroxyl group, and R2 represents a hydrogen atom, or R1 and R2 optionally form a cyclic structure together to represent a C2 to C3 alkylene chain).
    Type: Application
    Filed: November 1, 2016
    Publication date: November 22, 2018
    Applicants: ADABIO CO., LTD., OTSUKA PHARMACEUTICAL FACTORY, INC.
    Inventors: Katsuya HIRAISHI, Fumie JIMMA, Hiroyuki SOMA, Taro ADACHI, Masakazu ADACHI, Ippei YAMAOKA, Tomohiro KAGAWA
  • PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR NAFLD/NASH
    Publication number: 20180325975
    Abstract: The present invention provides a prophylactic and/or therapeutic agent for non-alcoholic fatty liver disease (NAFLD), and particularly non-alcoholic steatohepatitis (NASH) comprising an ume (Japanese apricot) juice concentrate or a processed product thereof. The prophylactic and/or therapeutic agent is obtained by utilizing a component contained in a plant or a processed product thereof, and hence is safe and easily taken. It has been confirmed that when the ume juice concentrate or the processed product thereof is orally administered to a streptozocin (STZ)-induced NAFLD model mouse or an STZ-induced NASH model mouse, liver fibrogenesis can be reduced.
    Type: Application
    Filed: November 25, 2016
    Publication date: November 15, 2018
    Applicants: ADABIO CO., LTD., OTSUKA PHARMACEUTICAL FACTORY, INC.
    Inventors: Katsuya HIRAISHI, Fumie JIMMA, Hiroyuki SOMA, Taro ADACHI, Masakazu ADACHI, Ippei YAMAOKA, Tomohiro KAGAWA